Huang James 4

What Happened

• James Huang, a director of Connect Biopharma Holdings Ltd (CNTB), is reporting a purchase (transaction code P) of 1,160,000 ordinary shares at $3.45 per share on 2026-03-31, a total reported value of $4,002,000. The Form 4 was filed on 2026-04-01.

Key Details

• Transaction date: 2026-03-31; filing date (Form 4): 2026-04-01 (timely filing).
• Price and amount: 1,160,000 shares @ $3.45 each = $4,002,000.
• Transaction type: P — open market or private purchase (as reported).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnote: The shares are reported in the name of Panacea Venture Healthcare Fund II, L.P. James Huang is the sole owner of Panacea Innovation Limited, which owns the GP of the fund; he may be deemed to share beneficial ownership but disclaims such beneficial ownership.

Context

• This was a purchase (addition of shares) reported by a director via an affiliated investment vehicle. Purchases are often considered more informative than routine sales because they increase exposure, but the filing does not state any motive. The structure of ownership means the economic owner is the fund, with Huang linked through ownership of the general partner entities.